Signaling network of Oncostatin M pathway

[1]  W. Fu,et al.  Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts , 2013, Journal of cellular physiology.

[2]  Jacqueline Murray,et al.  Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells. , 2012, Biochemical and biophysical research communications.

[3]  A. Cope,et al.  Monocytes Induce STAT3 Activation in Human Mesenchymal Stem Cells to Promote Osteoblast Formation , 2012, PloS one.

[4]  A. Pandey,et al.  Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis. , 2012, Molecular bioSystems.

[5]  G. Mayer,et al.  Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression. , 2011, American journal of physiology. Renal physiology.

[6]  A. Pandey,et al.  A Signaling Network of Thyroid-Stimulating Hormone. , 2011, Journal of proteomics & bioinformatics.

[7]  Gary D. Bader,et al.  NetSlim: high-confidence curated signaling maps , 2011, Database J. Biol. Databases Curation.

[8]  Rajesh Raju,et al.  A Comprehensive Curated Reaction Map of Leptin Signaling Pathway , 2011 .

[9]  Gary D. Bader,et al.  A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway , 2011, Database J. Biol. Databases Curation.

[10]  Ying Yue,et al.  Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3. , 2011, International journal of molecular medicine.

[11]  K. Migita,et al.  CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes , 2011, Arthritis research & therapy.

[12]  M. Hsiao,et al.  Simvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: a therapeutic benefit for arthritis. , 2011, Arthritis and rheumatism.

[13]  Jingwen Liu,et al.  Janus kinase activation by cytokine oncostatin M decreases PCSK9 expression in liver cells[S] , 2011, Journal of Lipid Research.

[14]  M. Pennell,et al.  Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines , 2011, BMC Cancer.

[15]  Gary D Bader,et al.  NetPath: a public resource of curated signal transduction pathways , 2010, Genome Biology.

[16]  Kumaran Kandasamy,et al.  PathBuilder - open source software for annotating and developing pathway resources , 2009, Bioinform..

[17]  Akhilesh Pandey,et al.  Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. , 2009, Methods in molecular biology.

[18]  M. Akiyama,et al.  Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. , 2008, American journal of human genetics.

[19]  T. Tatusova,et al.  Entrez Gene: gene-centered information at NCBI , 2006, Nucleic acids research.

[20]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[21]  M. Kedda,et al.  Oncostatin M: an interleukin‐6‐like cytokine relevant to airway remodelling and the pathogenesis of asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  James M. Eldred,et al.  The DNA sequence of human chromosome 7 , 2003, Nature.

[23]  Jingwen Liu,et al.  Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells , 2003, Oncogene.

[24]  A. Miyajima,et al.  Oncostatin M, a multifunctional cytokine. , 2003, Reviews of physiology, biochemistry and pharmacology.

[25]  Maria Jesus Martin,et al.  The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..

[26]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[27]  H. Baumann,et al.  Oncostatin M Regulates the Synthesis and Turnover of gp130, Leukemia Inhibitory Factor Receptor α, and Oncostatin M Receptor β by Distinct Mechanisms* , 2001, The Journal of Biological Chemistry.

[28]  W. Brück,et al.  Effects of Oncostatin M on Human Cerebral Endothelial Cells and Expression in Inflammatory Brain Lesions , 2001, Journal of neuropathology and experimental neurology.

[29]  H. Baumann,et al.  Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. , 2001, The Journal of biological chemistry.

[30]  S. Wang,et al.  Oncostatin M activates stat DNA binding and transcriptional activity in primary human fetal astrocytes: low- and high-passage cells have distinct patterns of stat activation. , 2000, Cytokine.

[31]  E. Benveniste,et al.  Oncostatin M Regulation of Interleukin‐6 Expression in Astrocytes , 2000, Journal of neurochemistry.

[32]  M. Hattori,et al.  The DNA sequence of human chromosome 21 , 2000, Nature.

[33]  Y Sakaki,et al.  The DNA sequence of human chromosome 21. , 2000, Nature.

[34]  Melanie E. Goward,et al.  The DNA sequence of human chromosome 22 , 1999, Nature.

[35]  H. Ihn,et al.  Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis. , 1999, Rheumatology.

[36]  C. Thiele,et al.  Inflammatory cytokines and HIV-1-associated neurodegeneration: oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons. , 1999, Journal of immunology.

[37]  C. Begley,et al.  Oncostatin M induces the differentiation of breast cancer cells , 1998, International journal of cancer.

[38]  Robert L Sutherland,et al.  Expression and function of members of the cytokine receptor superfamily on breast cancer cells , 1997, Oncogene.

[39]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.

[40]  R. Powers,et al.  Resonance assignments for Oncostatin M, a 24-kDa α-helical protein , 1996 .

[41]  R. Powers,et al.  Resonance assignments for Oncostatin M, a 24-kDa alpha-helical protein. , 1996, Journal of Biomolecular NMR.

[42]  S. Dower,et al.  Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. , 1994, The Journal of biological chemistry.

[43]  P. Linsley,et al.  Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M , 1990, Molecular and cellular biology.

[44]  G. Todaro,et al.  Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.